Joint Venture with Hettich
Directors bought $100,000 shares each in the CR ($100k is $100k, regardless of the price - they the satutus of negotiations, we don't ) Directors have a lot of skin in the game.
Moran sold 1,760,000 for $1,016,768 and then acquired 1,026,770 back in the CR at $318,299 and now holds above 5% again. SIs know more than us
Directors lent the company $1,000,000 unsecured 2 years ago
We have FDA approval ahead of others
Roth Capital Partners (US) have joined our Register
Brent Barnes ex Cochlear is a coup in this market
AND
I can't imagine having a product on show at ECCMID in April without a Distributor on board
Minny, I can see how the past 6 months looks like a roller coaster ride, however in context with our 10 year journey it seems that is how bio-tech works. I am a long term holder of 670,000 shares.
LBT Board is dull, colorless and boring with an impeccable corporate governance record.
If you want a constant stream of announcements from more speculative types I would suggest add some Lithium, Graphite or Uranium companies to you portfolio.
GLTAH
LBT Price at posting:
33.5¢ Sentiment: Hold Disclosure: Held
